Pharmacy Practice and Pharmaceutical Sciences: Workforce, Access and Digital Change

Summary

Pharmacy practice in the United States faces a workforce squeeze, uneven community access and early but fast-moving digital change. HRSA's projection, as summarized by an industry association, points to a shortfall of 30,400 full-time equivalent pharmacists ¹. A national workforce study found 25.5% of respondents likely or very likely to leave their current job within a year ¹. Retail prescription volume rose 13.7% over a period the source does not fully define ². Access is uneven: 22 Virginia localities have one or no community pharmacy ⁵, and rural residents and American Indian and Alaska Native populations face access gaps ⁷. European data shows community pharmacy services spreading, with a median of 26 services per country ⁸. AI use remains limited, with 3% of surveyed Canadian retail pharmacists using AI tools most of the time ⁹. Principal risks are workforce loss, access erosion and reliance on vendor claims. The outlook favors workforce planning, targeted access models and evidence-based digital adoption. Verified data on costs, reimbursement, waiting times and clinical outcomes was not found in the source pack.

Key findings

1. 1

   A large projected pharmacist shortfall in the United States

   HRSA's Health Workforce Simulation Model projects a shortfall of 30,400 full-time equivalent pharmacists. The horizon is a forecast, not an observed count ¹.

   Confidence: Medium
2. 2

   Community access is declining in at least one state

   The number of community pharmacies in Virginia has declined steadily over the period reviewed, and 22 localities have one or no community pharmacy within their borders ⁵.

   Confidence: High
3. 3

   Services are spreading across European countries

   Across 33 countries, 47 community pharmacy services were identified, with a median of 26 per country. Most services (77%, 36 of 47) were available in more countries in the latest period than earlier ⁸.

   Confidence: High
4. 4

   Better access is associated with more equitable medication use

   A Health Affairs study reported in a press release links better community pharmacy access with higher and more equitable prescription drug use across racial and ethnic groups. The result is an association, and the evidence comes from a press release ⁷.

   Confidence: Medium
5. 5

   AI use in pharmacy is early and the evidence is vendor-sourced

   Only 3% of surveyed Canadian retail pharmacists use AI tools most of the time, while 47% cite AI as the top driver of change. The vendor survey also reports higher effectiveness for pharmacy-specific tools, which has not been independently verified ⁹.

   Confidence: Qualitative

1Industry definition and scope

This report covers pharmacy practice, meaning the dispensing and clinical services delivered by community, hospital and employer-based pharmacists, and pharmaceutical sciences, meaning the research, manufacturing and quality functions that support medicines. The source pack covers practice and workforce in depth but contains little verified evidence on manufacturing or research and development, so the pharmaceutical sciences side is described only where sources touch it.

The geographic scope is mainly the United States. Comparison data comes from England and Wales ⁶, Canada ⁹, a cross-country European survey ⁸ and global workforce discussion. Each figure is labeled with its country, and the report does not add these figures together.

Terminology varies. Workforce sources count full-time equivalents ¹, while occupational statistics count jobs ⁴. These measures are not interchangeable. Reporting periods also differ, and several sources do not state a cut-off date. The report therefore uses 'latest available data' and avoids cross-source trend claims unless the source states its period.

Scope follows the source pack. Where a source is a vendor, association or press release, the report labels it that way.

2Market size, structure and value chain

The pack reports 325,200 pharmacist jobs in the base year of the United States occupational projections ⁴. This is a headcount of jobs, not a market value. The pack does not provide verified revenue, dispensing fee or total spending figures, so market size in money terms cannot be estimated from these sources.

Employment is shifting between settings. Drug Channels reports that retail pharmacist jobs fell by 8,200 in the latest period, while hospitals added 3,000 ⁴. This is a single period and a secondary citation, so it indicates direction rather than a measured trend.

The value chain runs from pharmacist education and licensure, through employment in community, hospital and employer settings, to dispensing and services. Workforce supply depends on the pipeline of graduates, which is tracked through AACP data ¹. Payers and employers shape demand: 68% of employers and 55% of health plans report using performance-based contracts for digital health tools ¹⁰.

Key stakeholders named in the pack include HRSA, the Bureau of Labor Statistics, the National Community Pharmacists Association (NCPA), ASHP, ACCP, Drug Channels, employers and health plans. Revenue models, such as fee-for-service or capitated payment for pharmacy services, are not verified in the pack and are not described.

• Pharmacist jobs in the base year of United States occupational projections 325,200jobs Observed United States, Latest available data [4]

Job counts are not market revenue. The report does not convert them into spending values.

3Customers, demand and adoption

Demand for pharmacy services is rising. One source reports that retail prescription volume rose 13.7% since an earlier period, but the cut-off date is unclear ². Demand growth is therefore directionally supported but cannot be dated precisely.

Patients need reachable pharmacies. Access is strongest where pharmacies are dense and weakest in rural and suburban areas. In England, the Department of Health and Social Care reported that 80% of people live within 20 minutes walking distance of a community pharmacy ⁶. A spatial study found that suburban and rural areas have poorer car access ⁶. US evidence points the same way: rural residents and American Indian and Alaska Native populations continue to face lack of community pharmacy access ⁷.

Payers and employers are the main purchasers of digital tools. Among employers, 68% use performance-based contracts for digital health tools, and 55% of health plans do the same ¹⁰. The source notes that early AI adoption by health plans and health systems has focused on administrative tasks ¹⁰.

Barriers include staffing limits, closures and uneven access. Expectations are changing as services widen. Across Europe, most mapped services became available in more countries in the latest period than earlier ⁸. The chart below shows the spread of services across countries.

The chart shows survey-based availability counts, not utilization or quality.

4Competitive landscape and key players

The source pack compares provider types rather than named competitors with market shares. Community retail pharmacies, hospital pharmacies and vendor platforms play different roles. Retail is contracting in job terms, while hospital employment grew by 3,000 ⁴. In Virginia, the total number of community pharmacies has declined steadily ⁵.

Pack data does not allow a verified cost or quality comparison between public, private and community providers. Only access and staffing data were retrieved, so claims about relative efficiency or quality are outside the evidence base.

Vendors compete for pharmacy and purchaser budgets. ShiftRx, a staffing-solutions vendor, cites NCPA data that 70% of pharmacies struggle to fill crucial roles, but this figure comes only from its own summary ³. TELUS Health reports that pharmacy-specific AI tools are rated 55 to 75% effective, against 38% for generic AI tools ⁹. These are vendor claims with no independent verification.

PHTI, an independent health technology research institute, surveyed digital health purchasing and provides a non-vendor view of purchaser behavior ¹⁰. Market concentration and market shares for these providers are not verified in the pack, and the report does not rank them.

Company examples are included to show roles and claims. The pack does not support a ranking.

5Technology, operations and workforce

Workforce strain is the central operational issue. HRSA's projected shortfall of 30,400 full-time equivalent pharmacists is a forecast ¹. In the national workforce study, 25.5% of respondents said they were likely or very likely to leave their jobs within a year ¹. A vendor summary reports that 70% of pharmacies struggle to fill key roles and that 89% of pharmacists are at high risk of burnout, but neither figure is traced to a primary study in the pack ³.

Policy attention is also turning to labor counting. A House Appropriations bill encourages the Bureau of Labor Statistics to work with HRSA and professional bodies on pharmacist labor-force counting ². This is a legislative proposal, not a binding requirement, and its status is not verified in the pack.

Technology adoption is uneven. Only 3% of surveyed Canadian retail pharmacists use AI tools most of the time, while 47% cite AI as the top driver of change ⁹. This gap between expectation and use suggests that AI is an emerging practice rather than an established one.

Established practice includes dispensing and in-person services. Emerging or experimental practice includes AI-assisted workflows and performance-based digital contracts ¹⁰. Productivity, error rates and time-savings data for either category are not verified in the pack.

• Projected pharmacist shortfall (forecast) 30,400full-time equivalents Forecast United States, Latest available data (projection horizon as stated by sourc... [1]
• Respondents likely or very likely to leave their job within a year 25.5percent Observed United States, Survey fielded in the latest period [1]

The table lists only figures in the pack. It shows source type so that readers can weigh evidence.

6Regulation, standards, risk and sustainability

Pharmacy regulation in the United States is set at state level for licensure and practice, with federal labor and health programs setting other conditions. The source pack does not contain verified text of state practice acts, licensing standards, safety rules or privacy requirements, so this report does not describe those rules. Readers should check the rules in their own jurisdiction before relying on any operational conclusion.

Binding rules are not identified in the pack for workforce, access or AI use. The House Appropriations bill on labor-force counting is a proposal, and its enactment is not verified ². Voluntary guidance and standards are not documented in the retrieved sources, beyond commentary on infrastructure access noted as a gap.

Equity and access are the main social risks. Rural and American Indian and Alaska Native populations face access gaps ⁷. Better access is associated with more equitable medication use, but this is an association ⁷. Pack evidence on the safety or equity effects of pharmacy-based AI or harm-reduction programs is absent.

Operational risks include staffing shortfalls, burnout, closures and reliance on vendor data. Environmental and sustainability factors are not addressed by any source in the pack, and the report does not assess them. Privacy and data-protection obligations for digital tools are also outside the verified evidence and need jurisdictional review.

This section does not provide legal or regulatory advice. Binding and proposed measures are separated where the pack allows.

7Challenges, opportunities and case examples

The main challenges are workforce shortage, community access erosion and missing cost data. A projected shortfall of 30,400 full-time equivalents ¹ combines with a Virginia decline in community pharmacies and 22 localities with one or no pharmacy ⁵. Without verified cost or waiting-time data, the report cannot judge whether access problems are driven by reimbursement or staffing.

Opportunities include service expansion and purchaser-led digital adoption. In Europe, 77% of mapped services (36 of 47) were available in more countries in the latest period than earlier ⁸. Performance-based contracts for digital tools are common among employers and health plans ¹⁰. AI tools for administrative tasks are the most visible emerging use ¹⁰.

Case example 1: Virginia. The Joint Commission on Health Care reports steady decline in community pharmacies and 22 localities with one or no pharmacy ⁵. This shows access loss at state level.

Case example 2: England and Wales. A peer-reviewed spatial accessibility study found poorer car access to pharmacies in suburban and rural areas ⁶. This shows that geography, not only supply, shapes access.

Case example 3: vendor claims. ShiftRx reports staffing shortage figures ³, and TELUS Health reports AI effectiveness ratings ⁹. These are vendor claims and are shown to illustrate the market, not to rank providers.

Examples are attributed. Vendor claims are marked as unverified.

8Outlook and strategic implications

In the near term, workforce pressure is likely to persist if the projected shortfall holds ¹. Retail employment is moving toward hospitals ⁴, and community access may weaken in rural and suburban areas ⁵⁶. These are directional readings from limited data, not forecasts with defined confidence.

Medium term, the evidence supports two scenarios. If labor-force counting improves and workforce planning is funded, access and staffing may stabilize ². If not, closures and shortages may widen. Digital adoption is likely to grow first in administrative tasks ¹⁰, with clinical AI use depending on evidence not yet verified in the pack ⁹.

Implications for employers and health plans: performance-based contracts can tie payment to measured results, but the pack does not show which measures work. Implications for pharmacy operators: staffing, retention and access planning are the most evidence-backed priorities. Implications for policymakers: labor-force data and access mapping are the clearest gaps. Implications for educators and researchers: workforce pipeline data and outcome studies are needed.

Scenarios are the writer's interpretation of the evidence, not forecasts from a model.

9Conclusion

The evidence points to a workforce-led access problem in United States pharmacy practice, supported by a forecast shortfall, declining community pharmacy numbers in at least one state, and early, vendor-driven digital adoption. The most defensible takeaways are that staffing is the main constraint, access is uneven, and cost, waiting-time and outcome evidence remains unverified.

How this was built

Sources

1. 1

   Clinical Pharmacist Shortage: The Pipeline Numbers Hiring Managers Need

   ACCP careers resource (summarizing HRSA National Center for Health Workforce Analysis and AACP data) Industry association

   careers.accp.com
2. 2

   Call for improved workforce planning for pharmacists in all industries to sustain the profession

   Jan D. Hirsch and co-authors, Journal of Managed Care and Specialty Pharmacy Peer-reviewed

   doi.org
3. 3

   Pharmacy Staffing Shortage: Causes, Impact & Solutions

   ShiftRx (vendor blog citing NCPA and other sources) Vendor report

   shiftrx.io
4. 4

   Pharmacist Job Outlook for Employers: Headcount, Openings per Year, and Your Hiring Plan

   ASHP careers resource (citing BLS and Drug Channels) Industry association

   careers.ashp.org
5. 5

   Access to Pharmacy Services in Virginia (RD66)

   Joint Commission on Health Care, Commonwealth of Virginia Regulator

   rga.lis.virginia.gov
6. 6

   Assessing spatial accessibility of community pharmacies in England and Wales using floating catchment area techniques

   Peer-reviewed study (PMC article) Peer-reviewed

   ncbi.nlm.nih.gov
7. 7

   New Study Ties Increased Community Pharmacy Access to Lower Racial and Ethnic Disparities in Medication Use

   National Pharmaceutical Council, University of Washington and University of Southern California (Health Affairs study, via press release) News report

   natlawreview.com
8. 8

   Evolution of community pharmacy services in the European Union and beyond: a cross-country survey of 33 national pharmacy organizations

   Springer, International Journal of Clinical Pharmacy Peer-reviewed

   link.springer.com
9. 9

   Pharmacy Trends Report (TELUS Health)

   TELUS Health Vendor report

   finance.yahoo.com
10. 10

    State of Digital Health Purchasing

    Pharmacy-adjacent purchasers survey by PHTI (Peterson Health Technology Institute) Market research

    phti.org